Reference health
Antibody response patterns in COVID‐19 patients with different levels of disease severity in Japan
22/22 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
4 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 22 checked references that resolve
resolves10.1016/S0140-6736(20)30183-5
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
resolves10.1001/jama.2020.2648
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
resolves10.1080/22221751.2020.1762515
Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients
resolves10.1126/science.abb5793
Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period
resolves10.1080/22221751.2020.1766382
Delayed specific IgM antibody responses observed among COVID-19 patients with severe progression
resolves10.1172/JCI138759
Kinetics of viral load and antibody response in relation to COVID-19 severity
resolves10.1016/j.cell.2020.02.058
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
resolves10.3201/eid2607.200841
Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease Patients
resolves10.1126/sciimmunol.abc8413
The receptor-binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients
resolves10.1038/s41423-020-0426-7
Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor
resolves10.7883/yoken.JJID.2020.061
Development of Genetic Diagnostic Methods for Detection for Novel Coronavirus 2019(nCoV-2019) in Japan
resolves10.1111/resp.13852
The role of <scp>SARS‐CoV</scp>‐2 antibodies in <scp>COVID</scp>‐19: Healing in most, harm at times
resolves10.1080/22221751.2020.1791738
High neutralizing antibody titer in intensive care unit patients with COVID-19
resolves10.1038/s41591-020-0965-6
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
resolves10.1038/s41577-020-00436-4
Not just antibodies: B cells and T cells mediate immunity to COVID-19
The 4 references without a DOI — listed, not checked
no DOI — not checkedWorld Health Organization.https://www.who.int/emergencies/diseases/novel-coronavirus-2019
no DOI — not checkedA systematic review of antibody mediated immunity to coronaviruses: antibody kinetics, correlates of protection, and association of antibody responses with severity of disease
no DOI — not checkedAnti‐Spike, anti‐Nucleocapsid and neutralizing antibodies in SARS‐CoV‐2 inpatients and asymptomatic carriers
no DOI — not checkedNeutralizing antibody responses to SARS‐CoV‐2 in a COVID‐19 recovered patient cohort and their implications
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1002/jmv.26899"><img src="https://citestamp.com/citestamped/10.1002/jmv.26899/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1002/jmv.26899)